Skip to main content
Clinical Trials/JPRN-UMIN000021426
JPRN-UMIN000021426
Completed
未知

Angiogenic Therapy Against Peripheral Arterial Disease with bone marrow derived MSC grown in platelet-rich plasma - ATPAD

ational Center for Global Health and Medicine0 sites5 target enrollmentMarch 14, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Center for Global Health and Medicine
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 14, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Center for Global Health and Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \* The patient with remarkable short life expectancy \* Patient with the past which is alcohol or drug dependence within 3 months of past \* Patient with malignant neoplasms and the patient who has the past within 5 years \* The patient who judged that there was a possibility of the malignant tumor \* Patient with severe diabetic retinopathy \* The patient who can't get informed consent \* The patient who judged that he was unsuitable to this trial

Outcomes

Primary Outcomes

Not specified

Similar Trials